We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > immunoglobulin

News List

DoP asks NPPA to review, verify Bharat Serum and Vaccine’s request of revising ceiling price of Human Normal Immunoglobulin expresspharma
December 25, 2020
The NPPA has dismissed the company's three contentions except for the applicability of GST.
Grifols Begins Production of Anti-SARS-CoV-2 Hyperimmune Immunoglobulin contractpharma
June 16, 2020
Potential anti-COVID-19 passive immune therapy is part of a collaboration with the U.S. government, first doses for trials are expected July 2020.
Kamada and Kedrion to develop immunoglobulin product for Covid-19 pharmaceutical-technology
April 30, 2020
Biopharmaceutical companies Kamada and Kedrion Biopharma have partnered to develop, manufacture and distribute a human plasma-derived polyclonal immunoglobulin (IgG) product for potential Covid-19 treatment.
FDA Approves Xembify®, 20% Subcutaneous Immunoglobulin americanpharmaceuticalreview
July 08, 2019
Grifols has announced Xembify®, its new 20% subcutaneous immunoglobulin, has been approved by the U.S. Food and Drug Administration (FDA). Xembify® is used to treat primary immunodeficiencies.